Calcium hydroxyapatite ceramic implants in bone tumour surgery
|
|
- Ira McCoy
- 5 years ago
- Views:
Transcription
1 Calcium hydroxyapatite ceramic implants in bone tumour surgery A LONG-TERM FOLLOW-UP STUDY A. Matsumine, A. Myoui, K. Kusuzaki, N. Araki, M. Seto, H. Yoshikawa, A. Uchida From Mie University School of Medicine and Osaka University Medical School, Japan We reviewed the results of 51 patients with benign bone tumours treated by curettage and implantation of calcium hydroxyapatite ceramic (CHA). The mean follow-up was 11.4 years (10 to 15.5). Post-operative fractures occurred in two patients and three had local recurrences; three had slightly limited movement of the adjacent joint and one had mild osteoarthritis. There were no allergic or neoplastic complications. In all cases, radiographs showed that the CHA was well incorporated into the host bone. Statistical analysis showed that absorption of the implanted CHA was greater in males (odds ratio, 6.2; 95% CI, 1.6 to 23.7) and younger patients (odds ratio, 0.6 for increase in age of 10 years; 95% CI, 0.91 to 0.99). However, the implanted CHA was not completely absorbed in any patient. We conclude that CHA is a useful and safe bone substitute for the treatment of benign bone tumours. A. Matsumine, MD, Assistant K. Kusuzaki, MD, Associate M. Seto, MD, Assistant A. Uchida, MD, Department of Orthopaedic Surgery, Mie University School of Medicine, Edobashi, Tsu-city, Mie , Japan. A. Myoui, MD, Assistant H. Yoshikawa, MD, Department of Orthopaedic Surgery, Osaka University Medical School, 2-2 Yamadaoka, Suita, Osaka , Japan. N. Araki, MD, Chief of the Department Department of Orthopaedic Surgery, Osaka Medical Center for Cancer and Cardiovascular Diseases, Nakamichi, Higashinariku, Osaka , Japan. Correspondence should be sent to Dr A. Matsumine British Editorial Society of Bone and Joint Surgery doi: / x.86b $2.00 J Bone Joint Surg [Br] 2004;86-B: Received 5 February 2003; Accepted after revision 20 January 2004 Large bone defects remaining after resection and curettage of benign bone tumours should be filled with a substitute to restore mechanical strength as soon as possible. Autologous bone grafts have the advantage of low risk of disease transmission and good osteoinduction. However, it may be difficult to obtain the quantity of bone graft required, particularly when the tumour is large or the patient is a child. The choices available include corticocancellous autograft, cortical or cancellous allograft, composite graft, ceramics, polymethylmethacrylate bone cement, bone marrow and demineralised bone matrix. The ideal bone substitute must be easily fabricated and preserved, biocompatible and biodegradable. In 1990, our short-term follow-up study of hydroxyapatite ceramic (CHA) for bone tumour surgery was the first to show that this material is biocompatible with bone and bone marrow. 1 Others have also reported short-term results 2-7 but there have been no reports of long-term clinical and radiographic studies of CHA in bone tumour surgery. Here, we present a series of 51 patients with benign bone tumours followed for a minimum of ten years after treatment by resection and curettage followed by implantation of CHA. Patients and Methods We retrospectively reviewed the results of 51 patients with benign bone tumours sequentially treated by curettage followed by implantation of CHA between April 1986 and January 1991 (Table I). The series comprised 32 males and 19 females, with a mean age of 24.6 years (7 to 59). The histological diagnoses were as follows: simple bone cysts, 13 patients; giant cell tumour of bone, 11; enchondroma, nine; fibrous dysplasia, eight; nonossifying fibroma, three; osteofibrous dysplasia, three; aneurysmal bone cyst, three; chondroblastoma, one. The locations were as follows: tibia, 16 patients; femur, 14; humerus, nine; phalanx, five; calcaneum, two; pelvis, two; scapula, one; fibula, one; talus, one. The mean follow-up was 11.4 years (10 to 15.5). Calcium hydroxyapatite ceramic implants. We used CHA in the form of granules (granule size 300 to 3000 µm) or porous blocks resembling pumice (porosity 35% to 48%; pore diameter 50 to 300 µm) (BONECERAM; Central Research Institute of Sumitomo Cement, Tokyo, Japan). The hydroxyapatite was sintered at 1150 C; the bending strength of each block was between 130 and 200 kgf/cm 2. The spatial dimensions of the blocks varied according to the shape and volume of the cavities. Operative technique. The tumour was exposed through an appropriately sized bone window. Careful and thorough curettage was performed using a curette and an airtome until cancellous bone was visible. Blocks and granules of gas-sterilized CHA were pressed in to VOL. 86-B, No. 5, JULY
2 720 A. MATSUMINE, A. MYOUI, K. KUSUZAKI, N. ARAKI, M. SETO, H. YOSHIKAWA, A. UCHIDA Table I. ceramic Details of 51 patients with benign bone tumours treated by resection and curettage followed by implantation of calcium hydroxyapatite Number Age (yrs) Gender Bone* Site in bone* Diagnosis Symptom at first visit Volume of the cavity (ml) Combination with autologous bone graft Complication Duration of followup (yrs) Radiographic staging at final follow-up 1 32 F Femur d-me GCT Knee pain 36 Yes No F Tibia p-me GCT Knee pain 72 Yes No A 3 17 M Humerus p-m SBC Shoulder pain 26 No No A 4 7 M Humerus D SBC No symptom 57 No Recurrence M Calcaneus SBC Heel pain 4 No No B 6 12 M Tibia D FD Leg pain 23 No No B 7 11 M Femur d-m EC Knee pain 12 Yes No A 8 37 M Femur p-m FD Thigh pain 24 No No A 9 53 M Humerus p-m SBC No symptom 48 No No M Femur p-md FD Thigh pain 48 Yes Fracture B F Scapula GCT Shoulder pain 6 No No M Iliac bone SBC No symptom 16 No No B M Femur D EC No symptom 48 No No M Femur p-m GCT Hip pain 72 Yes No A M Tibia p-me NOF No symptom 112 No No M Tibia p-m GCT Knee pain 80 Yes No B M Femur p-me GCT Knee pain 130 Yes No M Humerus p-m ABC No symptom 36 No Limited ROM F Femur p-m FD Thigh pain 8 No No 11 3B F Tibia D FD Leg pain 32 No No 11 3A F Tibia D FD Leg pain 11 No No F Humerus d-md FD Fracture 24 No Limited ROM A F Humerus p-md SBC Shoulder pain 21 No Recurrence A M Femur p-m SBC Hip pain 18 No No B M Femur p-m SBC Hip pain 20 No No B M Humerus D SBC Brachialgia 11 No No B M Tibia D OFD No symptom 19 Yes Fracture B M Femur p-m SBC Hip pain 6 No No B 29 5 M Femur p-m SBC Thigh pain 2 No No 11 3B 30 8 M Tibia D OFD Leg pain 12 Yes No B F p-phalanx p-m EC Finger pain 0.5 No No M Tibia p-me GCT Knee pain 80 Yes OA B F Tibia D OFD Leg pain 40 No No M Femur d-me GCT Knee pain 110 Yes No B M Tibia p-m GCT Knee pain 30 Yes No A M Tibia d-m GCT Ankle pain 3 No No A F Pubis SBC Pubic pain 10 No No F Tibia p-md FD No symptom 63 No No F p-phalanx p-md EC Swelling 1.5 No No A M Metacarpal D EC Swelling 0.8 No No B M Humerus p-m ABC Shoulder pain 60 No No B F p-phalanx D EC Swelling 0.5 No No F Tibia p-me GCT Knee pain 120 Yes Recurrence B F Tibia D EC Leg pain 12 Yes No F Calcaneus CB Heel pain 0.5 No No M Tibia D NOF No symptom 5 No No M Talus ABC Ankle pain 4 No No A F m-phalanx p-m EC Swelling 0.6 No Limited ROM M Femur d-m NOF No symptom 48 No No A F Humerus p-md EC Brachialgia 29 No No M Fibula D SBC Leg pain 6 No No B * p-; proximal; m, middle; d-, distal E, epiphysis; M, metaphysis; D, diaphysis GCT, giant cell tumour; SBC, simple bone cyst; FD, fibrous dysplasia; OFD, osteofibrous dysplasia; EC, enchondroma; NOF, non-ossifying fibroma; ABC, aneurysmal bone cyst; CB, chondroblastoma fill the bone defect. No other adjuvant treatment such as phenol or cryotherapy was used. The mean volume of the bone cavity was 32.5 ml (0.5 to 130). In 14 patients, CHA was used in combination with autologous bone graft. In six patients, internal fixation using plates and screws was used in addition to curettage, if the patient s bone was deemed to be too fragile. In 19 patients, the growth plate was still open at the time of the procedure. Assessment and statistical analysis. Assessment was based on clinical examination and radiography at the final followup. All assessments were performed by the musculoskeletal tumour service teams of Osaka University Medical School THE JOURNAL OF BONE AND JOINT SURGERY
3 CALCIUM HYDROXYAPATITE CERAMIC IMPLANTS IN BONE TUMOUR SURGERY 721 Stage 1 Clear margin Stage 2 Hazy margin Stage 3 Absorbed < 50% of the margin > 50% of the margin A B Fig. 1 Diagram showing the three stage radiographic classification. Stage 1, clear margin; stage 2, hazy margin; stage 3, absorbed margin. Stage 3 was subdivided into stage 3A, absorption less than 50% of the margin of CHA and stage 3B, absorption more than 50% of the margin of CHA. Table II. Relationship between radiographic staging at final follow-up and various factors Number of Radiographic staging at final follow-up Characteristics patients 2 3A 3B p value Number of patients Gender F M Age (yrs) < Location in body Inferior limb Non-inferior limb Type of bone Long tubular bone Non-long tubular bone Site in the long bone Diaphysis only Including metaphysis or epiphysis Volume of the cavity <20 (ml) (ml) Combination with autologous bone graft Yes No Duration of the follow-up <11 (yrs) (yrs) and Mie University School of Medicine, under the direct supervision of the senior author (AU). Radiographic findings were classified into three stages: stage 1, clear margin; stage 2, hazy margin; stage 3, absorbed margin. Stage 3 was subdivided further into stage 3A, absorption <50% of the margin of CHA and stage 3B, absorption >50% of the margin of CHA (Fig. 1). Post-operative CT or MRI was performed to detect local recurrence. In order to study factors affecting the absorption of the CHA, statistical analysis was performed using StatView statistical software (version 5.0; SAS Institute Inc. Cary, North Carolina). Univariate analysis was performed using VOL. 86-B, No. 5, JULY 2004
4 722 A. MATSUMINE, A. MYOUI, K. KUSUZAKI, N. ARAKI, M. SETO, H. YOSHIKAWA, A. UCHIDA Fig. 2a Fig. 2b Fig. 2c Radiographs of a 28-year-old man with an aneurysmal bone cyst of the proximal humerus (case 41), showing a) an anteroposterior view of the right shoulder with extensive osteolysis, b) clear margin of the CHA one month after operation, and c) absorbed margin of CHA more than 50% (stage 3B) 15.5 years after operation with increased density of the CHA implant and fusion of granules to each other. the Mann-Whitney U test for nonparametric data. When one-factor analysis of variance indicated a significant difference, multiple logistic regression analysis was used to estimate the odds ratio (OR) of absorption of the CHA implant; less than p < 0.05 was considered significant. Results Clinical findings. There were no adverse local effects such as excessive post-operative drainage or erythema, during the early post-operative period. No patient developed postoperative infection; no toxicity was detected by routine serological examinations; no allergic or neoplastic disease was observed during the follow-up period. Functionally three patients, one with an aneurysmal bone cyst of the proximal humerus, one with fibrous dysplasia of the diametaphyseal humerus, and one with enchondroma of the middle phalanx had a limited range of movement in joints adjacent to the lesions. One patient, with a giant cell tumour beneath the subchondral bone plate of the proximal tibia, had some knee pain with mild radiographic osteoarthritic changes eight years after surgery, but he suffered no limitation of daily activities. There were three local recurrences of tumour; two were from the group of 13 patients with a simple bone cyst, and one from the group of 11 patients with a giant cell tumour. The two patients with recurrence of a bone cyst did not require further surgery because there was no expansive growth of the lesions. The patient with recurrent giant cell tumour required repeat curettage and CHA implantation two years after the initial surgery. Two patients, one with fibrous dysplasia of the femur, and one with osteofibrous dysplasia of the tibia, suffered a post-operative fracture within two months of the initial procedure. Both these fractures united without deformity after immobilisation in a cast. Radiographic findings. All patients had good filling of their bone defects by CHA. Radiographs at the final follow-up were staged as follows: stage 2, in 19 patients; stage 3A, in 13; stage 3B, in 19 (Table II). No clear margins (stage 1) were detected at the final follow-up. Initial radiolucent lines and halos around CHA implants faded with time, and eventually disappeared. Radiographic density at the implant sites increased with time and some CHA blocks and granules fused to each other (Fig. 2). There was no displacement of an implant from its intra-osseous site. In skeletally immature patients, implanted CHA granules scattered within the bone and were eventually absorbed (Fig. 3). Progressive remodelling of any bony deformity resulting from the tumour occurred over time (Fig. 4). Longitudinal bone growth was not disturbed, even when CHA was implanted close to the growth plate. At the final follow-up, radiographs showed that the implanted CHA was well incorporated into the surrounding host bone in every patient but in no patient was it seen to be completely absorbed. Table II shows the radiographic staging at the final follow-up in the two groups. Univariate analysis demon- THE JOURNAL OF BONE AND JOINT SURGERY
5 CALCIUM HYDROXYAPATITE CERAMIC IMPLANTS IN BONE TUMOUR SURGERY 723 Radiographs of a nine-year-old boy with a simple bone cyst of the fibula (case 51), showing a) lytic change of the diaphysis, b) clear margin of the CHA one month after operation, and c) absorbed margin of CHA more than 50% (stage 3B) 10.4 years after operation. Fig. 3a Fig. 3b Fig. 3c Fig. 4a Fig. 4b Fig. 4c Anteroposterior radiographs of a 10-year-old girl with enchondroma of proximal phalanx (case 39), showing a) expansive growth of the tumour with thin cortex, b) clear margin of the implanted CHA one month after operation, and c) absorbed margin of the CHA less than 50% (stage 3A) 11.6 years after operation with remodelling of the deformity of the metaphysis. VOL. 86-B, No. 5, JULY 2004
6 724 A. MATSUMINE, A. MYOUI, K. KUSUZAKI, N. ARAKI, M. SETO, H. YOSHIKAWA, A. UCHIDA Table III. Multivariate analysis of factors predictive of radiographic absorption of the implanted CHA Variable Odds ratio 95% CI p value Gender Female 1 Male to Age (increasing by 10-year increments) to Table IV. Reports of results of CHA implantation following curettage of bone tumour Study Type of CHA Number of patients Uchida et al 1 CHA Inoue et al 2 CHA Yamaguchi et al 3 CHA 7 86 Yamamoto et al 4 CHA Joosten et al 5 HA cement 8 12 Irwin et al 6 Coralline HA Present study CHA Duration of follow-up (mths) strated that the odds rate of absorption of the implanted CHA was significantly higher for male patients (p < 0.01) and in patients less than 30 years of age (p < 0.05). Our data do not indicate a significant association between the odds rate of absorption of the implanted CHA and location in the body (lower limb vs upper; p = 0.09), type of the bone (long tubular bone vs short; p = 0.24), site in the bone (diaphysis only vs diaphysis with metaphysis or epiphysis; p = 0.72), volume of the cavity (p = 0.52), combination with autologous bone graft (p = 0.15) or duration of the followup period (p = 0.33). Multivariate analysis showed that absorption of the implanted CHA was significantly greater in males (OR, 6.2; 95% CI, 1.6 to 23.7) and younger patients (OR, 0.6 for an increase in age of 10 years; 95% CI, 0.91 to 0.99) (Table III). Discussion Calcium hydroxyapatite ceramic has been used for repair of bony defects resulting from severely comminuted fractures, 8 in spinal surgery 9 and arthroplasty. 10,11 The orthopaedic oncologist is often faced with large bony defects during surgical procedures to remove bone tumours. When the length of the cortical defect exceeds 75% of the cortical diameter, the open-section effect results, and this can greatly reduce the load-carrying capacity of the cortical bone, particularly under torsional loading. 12 Immediately after surgery, there is no difference in mechanical strength between bone filled with bone substitute and bone left empty. However, because bone substitute can act as a scaffold for new bone formation, bone filled with substitute can gradually become stronger against mechanical stress than a bone defect which is left empty. Although autologous bone graft has long been considered the ideal bone substitute, its disadvantages include limited availability, tumour implantation into the donor site, and the risk of pain, infection and nerve damage 13 at the donor site. Porous and granular CHA implanted into bony defects can provide a suitable framework for osteogenesis, and compares well with allografts and xenografts. 1,4 Shortterm follow-up studies have demonstrated the benefits of implanted CHA both biologically and mechanically 1-7 (Table IV). We noticed a slightly limited range of movement in joints adjacent to the lesions in three patients with an aneurysmal bone cyst of the proximal humerus, fibrous dysplasia of the distal metadiaphyseal humerus and an endochondroma of the middle phalanx, respectively. However, this stiffness was not due to hydroxyapatiteinduced fibrosis or arthritis, but rather to soft-tissue adhesion. There was no displacement of hydroxyapatite granules into the soft tissues or the joint space. One other patient, with a giant cell tumour beneath the subchondral bone plate of the proximal tibia, had slight knee pain with mild radiographic degenerative changes eight years after surgery. Yamamoto et al 4 did not detect degenerative changes in any joint in 75 patients who received CHA implants after resection of benign bone tumours, but the mean follow-up was short (41.3 months). Itokazu et al 8 successfully treated tibial plateau fractures in 17 patients using CHA as a bone substitute, without progression of osteoarthritis. In two cases with lesions in the lower limb (fibrous dysplasia of the femur, and osteofibrous dysplasia of the tibia), post-operative fractures occurred within two months of CHA implantation. In the early post-operative period, the mechanical strength of CHA-implanted bone tends to be overestimated because of its dense appearance on radiographs. Hamson et al 14 reported that, within six months of implantation, there was no significant difference in mechanical strength between CHA and autologous cortical bone. Vuola et al 15 showed that, at 12 weeks, the compressive strength of CHA was greater than that of cancellous bone. For patients with bone tumours in the lower limbs in which it occupies more than half of the medullary cavity, as shown by CT scan, we recommend that full weight-bearing is delayed for at least three months. The fractures in the present series united after immobilisation, with retention of the CHA implant and without deformity. In our study, although thorough curettage of the tumour was performed, there were three local recurrences; two of these patients had simple bone cysts (rate of recurrence 15%) but they did not require re-operation, because the lesion did not expand. Curettage with autogenous bone graft is the most common treatment for simple bone cysts, despite reported local recurrence rates of 30% to 50%. 16 The other patient with recurrence had a giant cell tumour (1 of 11; rate of recurrence 9%). There have been reports of recurrence rates of between 12% and 25% for giant cell tumour The small number of patients and the noncom- THE JOURNAL OF BONE AND JOINT SURGERY
7 CALCIUM HYDROXYAPATITE CERAMIC IMPLANTS IN BONE TUMOUR SURGERY 725 parative design of our study are not suitable for statistical comparison of local recurrence rates. In patients implanted with CHA, there was no disease transmission, no potential increase of infection, no toxic effects, and no allergic or neoplastic induction. In our study, radiographs show: 1) new bone formation within the CHA; 2) hazy or partially absorbed margin of the CHA; 3) more significant absorption of the CHA in skeletally immature patients and in male patients; 4) normal fracture healing and 5) corrective remodelling of the affected bone. Because no quantitative measurements are available for evaluation of bone ingrowth into porous material, it is not possible accurately to compare ingrowth rates of different bone substitutes. However, we have previously reported bone ingrowth into the pore structures of implanted CHA at one year after implantation. 1 Such human histological findings are consistent with the results of animal experiments, 20,21 although bone ingrowth into pore structures took place more slowly in humans. Bioabsorption of CHA in vivo over time is not completely understood, due to the lack of long-term follow-up studies (Table IV). Radiographically, in no patient was the CHA seen to disappear completely, but it was partially absorbed at final follow-up. Yamaguchi et al 3 described the degradation-resistant character of synthetic hydroxyapatite blocks used to fill bony defects, followed for 78 to 109 months. By contrast, Goto et al 22 recently reported that synthetic hydroxyapatite blocks implanted into an iliac bone defect harvested for grafting, were completely absorbed and replaced by newly formed bone, 79 months after implantation. A recent epidemiological study has shown that peak bone mass occurs between the ages of 21 and 30 years, and that bone density correlates with youth and male gender. 23 Static histomorphometric analysis using human iliac crest bone biopsies, has demonstrated that there is a linear decline in trabecular bone volume with age. 24 Therefore absorption of implanted CHA should correlate with normal bone turnover, although biodegradability of CHA appears to be influenced by other factors including pore diameter, porosity, calcined temperature and the shape of the implant. 22 In our study, CHA showed several favourable features including lack of adverse effects, ease of manufacture, ease of preservation and good adjustment of shape. Our results indicate that CHA is a useful and safe bone substitute in the treatment of benign bone tumours. No benefits in any form have been received or will be received from a commercial party related directly or indirectly to the subject of this article. References 1. Uchida A, Araki N, Shinto Y, et al. The use of calcium hydroxyapatite ceramic in bone tumour surgery. J Bone Joint Surg [Br] 1990;72-B: Inoue O, Ibaraki K, Shimabukuro H, Shingaki Y. Packing with high-porosity hydroxyapatite cubes alone for the treatment of simple bone cyst. Clin Orthop 1993; 293: Yamaguchi K, Hirano T, Yoshida G, Iwasaki K. Degradation-resistant character of synthetic hydroxyapatite blocks filled in bone defects. Biomaterials 1995;16: Yamamoto T, Onga T, Mariu T, Mizuno K. Use of hydroxyapatite to fill cavities after excision of benign bone tumours: clinical results. J Bone Joint Surg [Br] 2000;82-B: Joosten U, Joist A, Frebel T, Walter M, Langer M. The use of an in situ curing hydroxyapatite cement as an alternative to bone graft following removal of enchondroma of the hand. J Hand Surg [Br] 2000;25: Irwin RB, Bernhard M, Biddinger A. Coralline hydroxyapatite as bone substitute in orthopedic oncology. Am J Orthop 2001;30: Heise U, Osborn JF, Duwe F. Hydroxyapatite ceramic as a bone substitute. Int Orthop 1990;14: Itokazu M, Matsunaga T, Ishii M, Kusakabe H, Wyni Y. Use of arthroscopy and interporous hydroxyapatite as a bone graft substitute in tibial plateau fractures. Arch Orthop Trauma Surg 1996;115: Cook SD, Dalton JE, Tan EH, et al. In vivo evaluation of anterior cervical fusions with hydroxyapatite graft material. Spine 1994;19: Hernandez Cortes P, Najera Sagastume OO, Mesa Ramos F, Pajares Lopez M. Hydroxyapatite-coated stems with metaphyseal and diaphyseal press-fit: eleven-year follow-up result. Acta Orthop Belg 2002;68: Epinette JA, Manley MT, D Antonio JA, Edidin AA, Capello WN. A 10-year minimum follow-up of hydroxyapatite-coated threaded cups: clinical, radiographic and survivorship analyses with comparison to the literature. J Arthroplasty 2003;18: Frankel VH, Burstein AH. Load capacity of tubular bone. In: Kenedi, RM, ed. Biomechanics and related bio-engineering topics. Oxford, etc: Pergamon Press, 1965: Younger EM, Chapman MW. Morbidity at bone graft donor site. J Orthop Trauma 1986;3: Hamson KR, Toth JM, Stiehl JB, Lynch KL. Preliminary experience with a novel model assessing in vivo mechanical strength of bone grafts and substitute materials. Calcif Tissue Int 1995;57: Vuola J, Taurio R, Goransson H, Asko-Seljavaara S. Compressive strength of calcium carbonate and hydroxyapatite implants after bone-marrow-induced osteogenesis. Biomaterials 1998;19: Neer CS, Francis KC, Johnston AD, Kiernan HA Jr. Current concepts on the treatment of solitary unicameral bone cyst. Clin Orthop 1973;97: Trieb K, Bitzan P, Lang S, Dominkus M, Kotz R. Recurrence of curetted and bonegrafted giant-cell tumours with and without adjuvant phenol therapy. Eur J Surg Oncol 2001;27: Blackley HR, Wunder JS, Davis AM, et al. Treatment of giant-cell tumors of long bones with curettage and bone-grafting. J Bone Joint Surg [Am] 1999;81-A: Turcotte RE, Wunder JS, Isler MH, et al. Giant cell tumor of long bone: a Canadian Sarcoma Group study. Clin Orthop 2002;397: Uchida A, Nade SM, McCartney ER, Ching W. The use of ceramics for bone replacement: a comparative study of three different porous ceramics. J Bone Joint Surg [Br] 1984;66-B: Uchida A, Nade S, McCartney E, Ching W. Bone ingrowth into three different porous ceramics implanted into the tibia of rats and rabbits. J Orthop Res 1985;3: Goto T, Kojima T, Lijima T, et al. Resorption of synthetic porous hydroxyapatite and replacement by newly formed bone. J Orthop Sci 2001;6: Lin JD, Chen JF, Chang HY, Ho C. Evaluation of bone mineral density by quantitative ultrasound of bone in 16,862 subjects during routine health examination. Br J Radiol 2001;74: Thomsen JS, Ebbesen EN, Mosekilde L. Relationships between static histomorphometry and bone strength measurements in human iliac crest bone biopsies. Bone 1998;22: VOL. 86-B, No. 5, JULY 2004
Radiological and histological analysis of synthetic bone grafts in recurring giant cell tumour of bone: a retrospective study
Journal of Orthopaedic Surgery 2010;18(1):63-7 Radiological and histological analysis of synthetic bone grafts in recurring giant cell tumour of bone: a retrospective study Hiroyuki Hattori, Hiroaki Matsuoka,
More informationTreatment of bone defect with calcium phosphate cement subsequent to tumor curettage in pediatric patients
ONCOLOGY LETTERS 11: 247-252, 2016 Treatment of bone defect with calcium phosphate cement subsequent to tumor curettage in pediatric patients TOMOKI NAKAMURA, AKIHIKO MATSUMINE, KUNIHIRO ASANUMA, TAKAO
More informationMARK D. MURPHEY MD, FACR. Physician-in-Chief, AIRP. Chief, Musculoskeletal Imaging
ALPHABET SOUP AND CYSTIC LESIONS OF THE BONE MARK D. MURPHEY MD, FACR Physician-in-Chief, AIRP Chief, Musculoskeletal Imaging ALPHABET SOUP AND CYSTIC LESIONS OF THE BONE Giant cell tumor (GCT) Unicameral
More informationCalcium Phosphate Cement
Calcium Phosphate Cement Fast-Setting Bone Graft and AutoGraft Extender. * Ossilix is a high performance next generation calcium phosphate cement indicated for filling bony defects in cancellous bone.
More informationSolitary Bone Cyst of the Lunate: A Case Report
Cronicon OPEN ACCESS ORTHOPAEDICS Case Report Solitary Bone Cyst of the Lunate: A Case Report MihirDesai* and Shivanand Bandekar Department of Orthopedics, Goa Medical College, Goa, India *Corresponding
More informationCASE STUDY: PRO-DENSE Injectable Regenerative Graft Used to Backfill a Bone Cavity Following Resection of a Giant Cell Tumor
: PRO-DENSE Used to Backfill a Bone Cavity Following Resection of a Giant Cell Tumor Contributed by: Matthew J. Seidel, MD* Lauren A. Schwartz, NP Scottsdale, AZ *Dr. Seidel is a paid consultant for Wright
More informationAn Assessment of Fate of CHA Blocks Used in the Cystic Lesions of Bone.
Original Article ISSN (O):2395-2822; ISSN (P):2395-2814 An Assessment of Fate of CHA Blocks Used in the Cystic Lesions of Bone. Pervaind Sharma 1, Asif Iqbal 2, Najmul Huda 3, Ajay Pant 4 1 Associate Professor,
More informationchronos Bone Void Filler. Beta-Tricalcium Phosphate ( β-tcp) bone graft substitute.
chronos Bone Void Filler. Beta-Tricalcium Phosphate ( β-tcp) bone graft substitute. Osteoconductive Resorbable Synthetic chronos Bone Void Filler chronos granules and preforms are synthetic, porous, osteoconductive,
More informationBone Void Filler. Callos. The Next Generation in Calcium Phosphate Cement A COLSON ASSOCIATE
Callos Bone Void Filler The Next Generation in Calcium Phosphate Cement A COLSON ASSOCIATE Callos Calcium Phosphate Cement Callos is a high performance next generation calcium phosphate cement indicated
More informationSkeletal Radiology. Solitary (unicameral) bone cyst. The fallen fragment sign revisited
Skeletal Radiol (1989) 18:261-265 Skeletal Radiology Solitary (unicameral) bone cyst The fallen fragment sign revisited S. Struhl, M.D., C. Edelson, M.D., H. Pritzker, M.D., L.P. Seimon, M.D., and H.D.
More informationNEW FIXATION STRATEGIES FOR OSTEOPOROTIC BONE
NEW FIXATION STRATEGIES FOR OSTEOPOROTIC BONE THE PROBLEMS Fixation failure Malunion F 83 yrs 2 Months 6 Months F 81 yrs 3 Months FIXATION AUGMENTATION TECHNIQUES (FATs) Surgical procedures aimed at increasing
More informationThe Radiology Assistant : Bone tumor - well-defined osteolytic tumors and tumor-like lesions
Bone tumor - well-defined osteolytic tumors and tumor-like lesions Henk Jan van der Woude and Robin Smithuis Radiology department of the Onze Lieve Vrouwe Gasthuis, Amsterdam and the Rijnland hospital,
More informationInion BioRestore. Bone Graft Substitute. Product Overview
Inion BioRestore Bone Graft Substitute Product Overview Inion BioRestore Introduction Inion BioRestore is a synthetic bone graft substitute, which remodels into bone and is easy to use. Inion BioRestore
More informationAdvice sheet for Surgeons and Radiologists. Radiographic appearance of CERAMENT
Advice sheet for Surgeons and Radiologists Radiographic appearance of CERAMENT The structure and function of CERAMENT CERAMENT is an osteoconductive bone graft substitute which consists of hydroxyapatite
More informationIntercalary Femur and Tibia Segmental Allografts Provide an Acceptable Alternative in Reconstructing Tumor Resections
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH Number 426, pp. 97 102 2004 Lippincott Williams & Wilkins Intercalary Femur and Tibia Segmental Allografts Provide an Acceptable Alternative in Reconstructing
More informationBonAlive Clinical Cases
BonAlive Clinical Cases Inhibition of bacterial growth Osteostimulation* Bioactive bone bonding *Non-osteoinduction BonAlive mechanism of action BonAlive composition: 53% SiO 2, 23% Na 2 O, 20% CaO, 4%
More informationEthan M. Braunstein, M.D. 1, Steven A. Goldstein, Ph.D. 2, Janet Ku, M.S. 2, Patrick Smith, M.D. 2, and Larry S. Matthews, M.D. 2
Skeletal Radiol (1986) 15:27-31 Skeletal Radiology Computed tomography and plain radiography in experimental fracture healing Ethan M. Braunstein, M.D. 1, Steven A. Goldstein, Ph.D. 2, Janet Ku, M.S. 2,
More informationRadiology Case Reports. Bone Graft Extruded From an Intramedullary Nail Tract in the Tibia. Penelope J. Galbraith, M.D., and Felix S. Chew, M.D.
Radiology Case Reports Volume 2, Issue 4, 2007 Bone Graft Extruded From an Intramedullary Nail Tract in the Tibia Penelope J. Galbraith, M.D., and Felix S. Chew, M.D. A 33-year-old man presented for follow
More informationsynthetic CANCELLOUS BONE technical monograph Presented by Barbara Blum, Ph.D.
C E L L P L E X TCP synthetic CANCELLOUS BONE technical monograph Presented by Barbara Blum, Ph.D. TECHNICAL MONOGRAPH CELLPLEX TCP SYNTHETIC CANCELLOUS BONE CELLPLEX TCP synthetic CANCELLOUS BONE introduction
More informationADVANCED BONE GRAFT SYSTEM OVERVIEW
ADVANCED BONE GRAFT SYSTEM OVERVIEW NANOSS BIOACTIVE ADVANCED BONE GRAFT Table Of Contents INTRODUCTION System Overview... 1 NANOSS BIOACTIVE COMPONENTS Comparison of nanoss Bioactive and Human Bone...
More informationThe injectable, self-setting calcium phosphate bone graft substitute.
The injectable, self-setting calcium phosphate bone graft substitute. With a porous architecture similar to natural bone. STRUCSURE CP Bone Graft Substitute Because simplicity matters STRUCSURE CP Bone
More informationTotal Hip Replacement in Diaphyseal Aclasis: A Case Report
ISPUB.COM The Internet Journal of Orthopedic Surgery Volume 6 Number 1 Total Hip Replacement in Diaphyseal Aclasis: A Case Report V Singh, S Carter Citation V Singh, S Carter.. The Internet Journal of
More informationLaura M. Fayad, MD. Associate Professor of Radiology, Orthopaedic Surgery & Oncology The Johns Hopkins University
Society of Pediatric Radiology, May 2013 Laura M. Fayad, MD Associate Professor of Radiology, Orthopaedic Surgery & Oncology The Johns Hopkins University Describes surgical techniques that resect and reconstruct
More informationFIBROUS CORTICAL DEFECT AND NON-OSSIFYING FIBROMA
POSTGRAD. MED. J. (1965), 41, 672. FIBROUS CORTICAL DEFECT AND NON-OSSIFYING FIBROMA PETER G. BULLOUGH, M.B., Ch.B. JON WALIFY, F.R.C.S. Nuffield Department of Orthopaedic University of Oxford, Surgery,
More informationTreatment of Distal Radius Bone Defects with Injectable Calcium Sulphate Cement
Treatment of Distal Radius Bone Defects with Injectable Calcium Sulphate Cement Deng Lei, Ma Zhanzhong, Yang Huaikuo, Xue Lei and Yang Gongbo Orthopaedic Department, Beijing XiYuan Hospital, China Academy
More informationLawrence A. DiDomenico, DPM, FACFAS
Lawrence A. DiDomenico, DPM, FACFAS Adjunct Professor, Kent State University College of Podiatric Medicine, Cleveland, Ohio USA Director, Reconstructive Rearfoot & Ankle Surgical Fellowship, Ankle and
More informationOrthopedic & Sports Medicine, Bay Care Clinic, 501 N. 10th Street, Manitowoc, WI Procedure. Subtalar arthrodesis
OSTEOAMP Allogeneic Morphogenetic Proteins Subtalar Nonunions OSTEOAMP Case Report SUBTALAR NONUNIONS Dr. Jason George DeVries and Dr. Brandon M. Scharer Orthopedic & Sports Medicine, Bay Care Clinic,
More informationIsolated congenital anterolateral bowing of the fibula : A case report with 24 years follow-up
Acta Orthop. Belg., 2009, 75, 842-846 CASE REPORT Isolated congenital anterolateral bowing of the fibula : A case report with 24 years follow-up Karolien LELIEFELD, Hans VAN DER SLUIJS, Ibo VAN DER HAVEN
More information4/28/2010. Fractures. Normal Bone and Normal Ossification Bone Terms. Epiphysis Epiphyseal Plate (physis) Metaphysis
Fractures Normal Bone and Normal Ossification Bone Terms Epiphysis Epiphyseal Plate (physis) Metaphysis Diaphysis 1 Fracture Classifications A. Longitudinal B. Transverse C. Oblique D. Spiral E. Incomplete
More informationBone Composition. Bone is very strong for its relatively light weight The major components of bone are:
Human Bones Bone Composition Bone is very strong for its relatively light weight The major components of bone are: Calcium carbonate Calcium phosphate Collagen Water Cortical Bone Spongy Bone Medullary
More informationAnabolic Therapy With Teriparatide Indications Beyond Osteoporosis
Anabolic Therapy With Teriparatide Indications Beyond Osteoporosis Andreas Panagopoulos MD, PhD Upper Limb & Sports Medicine Orthopaedic Surgeon Assistant Professor, University of Patras Outline Teriparatide
More informationUnicameral bone cysts are benign, fluid-filled cavities
Endoscopic Surgery for Symptomatic Unicameral Bone Cyst of the Proximal Femur Wataru Miyamoto, M.D., Masato Takao, M.D., Youichi Yasui, M.D., Shinya Miki, M.D., and Takashi Matsushita, M.D. Abstract: Recently,
More informationThe Radiology Assistant : Bone tumor - ill defined osteolytic tumors and tumor-like lesions
Bone tumor - ill defined osteolytic tumors and tumor-like lesions Henk Jan van der Woude and Robin Smithuis Radiology department of the Onze Lieve Vrouwe Gasthuis, Amsterdam and the Rijnland hospital,
More informationFracture risk in unicameral bone cyst. Is magnetic resonance imaging a better predictor than plain radiography?
Acta Orthop. Belg., 2011, 77, 230-238 ORIGINAL STUDY Fracture risk in unicameral bone cyst. Is magnetic resonance imaging a better predictor than plain radiography? Nathalie PiREAU, Antoine DE GHELDERE,
More informationDevelopments in bone grafting in veterinary orthopaedics part one
Vet Times The website for the veterinary profession https://www.vettimes.co.uk Developments in bone grafting in veterinary orthopaedics part one Author : John Innes, Peter Myint Categories : Vets Date
More informationCASE PRESENTATION. Dr. Faseeh Shahab PGY3 Orthopaedic Resident, Khyber Teaching Hospital, Peshawar, PAKISTAN
CASE PRESENTATION Dr. Faseeh Shahab PGY3 Orthopaedic Resident, Khyber Teaching Hospital, Peshawar, PAKISTAN CASE PRESENTATION - History Ms. SB, 30yo Afghan National Presented with 3 months history of Swelling
More informationThe use of unidirectional porous β-tricarcium phosphate in surgery for calcaneal fractures: A report of four cases
The use of unidirectional porous β-tricarcium phosphate in surgery for calcaneal fractures: A report of four cases by Shigeo Izawa 1*, Toru Funayama 2, Masashi Iwasashi 1, Toshinori Tsukanishi 3, Hiroshi
More informationIliac aneurysmal bone cyst treated by cystoscopic controlled curettage
Accepted February 13th, 2004 Iliac aneurysmal bone cyst treated by cystoscopic controlled curettage Ludwig Schwering¹, Markus Uhl² and Georg W. Herget( )¹ ¹ Department of Orthopaedics and Traumatology,
More informationThe Outcome of Bone Substitute Wedges in Medial Opening High Tibial Osteotomy
Send Orders for Reprints to reprints@benthamscience.net The Open Orthopaedics Journal, 2013, 7, 373-377 373 Open Access The Outcome of Bone Substitute Wedges in Medial Opening High Tibial Osteotomy N.M.
More informationOsteomyelitis in infancy and childhood: A clinical and diagnostic overview M. Mearadji
Osteomyelitis in infancy and childhood: A clinical and diagnostic overview M. Mearadji International Foundation for Pediatric Imaging Aid Introduction Osteomyelitis is a relative common disease in infancy
More informationGraftys. Cross-selling. Indications. Comparison. Basic Science. Graftys 415 rue Claude Nicolas Ledoux Aix en Provence Cedex 4
2015 Graftys Cross-selling Indications Comparison Graftys 415 rue Claude Nicolas Ledoux 13854 Aix en Provence Cedex 4 www.graftys.com Basic Science Graftys QuickSet Training 1 Where to use QuickSet? Revision
More informationBone Grafting and Bone Graft Substitutes. Original Author: James Krieg, MD Revision Author: David Hak, MD Last Revision May 2010
Bone Grafting and Bone Graft Substitutes Original Author: James Krieg, MD Revision Author: David Hak, MD Last Revision May 2010 Bone Graft Function Structural support of articular fracture Tibial plateau
More informationChapter 5 The Skeletal System
Chapter 5 The Skeletal System The Skeletal System Parts of the skeletal system Bones (skeleton) Joints Cartilages Ligaments (bone to bone)(tendon=bone to muscle) Divided into two divisions Axial skeleton:
More informationCELLPLEX TCP SYNTHETIC CANCELLOUS BONE
CELLPLEX TCP SYNTHETIC CANCELLOUS BONE 129257-9 The following languages are included in this packet: English (en) Deutsch (de) Nederlands (nl) Français (fr) Español (es) Italiano (it) Português (pt) -
More informationChoice of spacer material for HTO! P. Landreau, MD Chief of Surgery Aspetar, Orthopaedic and Sports Medicine Hospital Doha, Qatar
Choice of spacer material for HTO! P. Landreau, MD Chief of Surgery Aspetar, Orthopaedic and Sports Medicine Hospital Doha, Qatar High Tibial Osteotomy: HTO! Valgisation HTO Intended to transfer the mechanical
More informationGeneral osteology. General anatomy of the human skeleton. Development and classification of bones. The bone as a multifunctional organ.
General osteology. General anatomy of the human skeleton. Development and classification of bones. The bone as a multifunctional organ. Composed by Natalia Leonidovna Svintsitskaya, Associate professor
More informationAPMA 2018 Radiology Track Bone Tumors When to say Gulp!
APMA 2018 Radiology Track Bone Tumors When to say Gulp! DANIEL P. EVANS, DPM, FACFAOM Professor, Department of Podiatric Medicine and Radiology Dr. Wm. Scholl College of Podiatric Medicine Conflict of
More informationChondroblastoma of bone
Chronology Chondroblastoma of bone LONG-TERM RESULTS AND FUNCTIONAL OUTCOME AFTER INTRALESIONAL CURETTAGE R. Suneja, R. J. Grimer, M. Belthur, L. Jeys, S. R. Carter, R. M. Tillman, A. M. Davies From The
More informationAn Introduction to the Skeletal System Skeletal system includes Bones of the skeleton Cartilages, ligaments, and connective tissues
An Introduction to the Skeletal System Skeletal system includes Bones of the skeleton Cartilages, ligaments, and connective tissues Functions of the Skeletal System Support Storage of minerals (calcium)
More informationOPERATIVE TECHNIQUE. CONSTRUX Mini PTC. Mini PTC Spacer System
OPERATIVE TECHNIQUE CONSTRUX Mini PTC Mini PTC Spacer System TABLE OF CONTENTS Introduction 1 Operative Technique 2 Part Numbers 6 Indications For Use 7 INTRODUCTION 1 INTRODUCTION The CONSTRUX Mini PTC
More informationHYDROXYAPATITE IN REVISION OF TOTAL HIP REPLACEMENTS WITH MASSIVE ACETABULAR DEFECTS
HYDROXYAPATITE IN REVISION OF TOTAL HIP REPLACEMENTS WITH MASSIVE ACETABULAR DEFECTS 4- TO 10-YEAR CLINICAL RESULTS H. OONISHI, Y. IWAKI, N. KIN, S. KUSHITANI, N. MURATA, S. WAKITANI, K. IMOTO From Osaka-Minami
More informationBasic Principles of Fractures & Easily Missed Fractures. Mr Irfan Merchant Trauma & Orthopaedic Registrar Bedford Hospital, East of England
Basic Principles of Fractures & Easily Missed Fractures Mr Irfan Merchant Trauma & Orthopaedic Registrar Bedford Hospital, East of England Objectives Types Fracture Patterns Fracture Healing Assessing
More informationPRO-STIM Injectable Inductive Graft TECHNICAL MONOGRAPH
PRO-STIM Injectable Inductive Graft TECHNICAL MONOGRAPH PRO-STIM Injectable Inductive Graft TECHNICAL MONOGRAPH Headline Contents Headline Appendix 4 5 7 8 13 14 Clinical Benefits Self-Forming Porous Scaffold
More informationMUSCULOSKELETAL RADIOLOGY
MUSCULOSKELETAL RADOLOGY SECTON www.cambridge.org Achilles tendonopathy/rupture Characteristics Describes pathology of the combined tendon of the gastro-soleus complex, which inserts onto the calcaneum.
More informationGIANT CELL-RICH OSTEOSARCOMA: A CASE REPORT
Nagoya J. Med. Sci. 59. 151-157, 1996 CASE REPORTS GIANT CELL-RICH OSTEOSARCOMA: A CASE REPORT KEIJI SATO!, SHIGEKI YAMAMURA!, HISASHI IWATA!, HIDESHI SUGIURA 2, NOBUO NAKASHIMA 3 and TETSURO NAGASAKA
More informationARMS. Reconstruction of Large Femur and Tibia Defect with Free Vascularized Fibula Graft and Locking Plate INTRODUCTION.
Original Article ARMS Archieves of Reconstructive Microsurgery pissn 2383-5257 eissn 2288-6184 Arch Reconstr Microsurg 2015;24(2):68-74 http://dx.doi.org/10.15596/arms.2015.24.2.68 Reconstruction of Large
More informationTechnique Guide. chronos Strip. Osteoconductive betatricalcium phosphate ( -TCP) composite.
Technique Guide chronos Strip. Osteoconductive betatricalcium phosphate ( -TCP) composite. Table of Contents Introduction chronos Strip 2 Indications and Contraindications 3 Surgical Technique Preparation
More informationThe long term fate of the fibula when used as an intraosseous graft
Acta Orthop. Belg., 2004, 70, 322-326 The long term fate of the fibula when used as an intraosseous graft Onkar N. NAGI, Mandeep S. DHILLON, Sameer AGGARWAL From the Post Graduate Institute of Medical
More informationDisclosures. Giant Cell Rich Tumors of Bone. Outline. The osteoclast. Giant cell rich tumors 5/21/11
Disclosures Giant Cell Rich Tumors of Bone Andrew Horvai, MD, PhD Associate Clinical Professor, Pathology This lecture discusses "off label" uses of a number of pharmaceutical agents. The speaker is describing
More informationThe Skeletal System. Mosby items and derived items 2010, 2006, 2002, 1997, 1992 by Mosby, Inc., an affiliate of Elsevier Inc.
The Skeletal System Functions of Skeletal System Provides internal framework that supports the body Protects internal organs Helps fight disease by producing white blood cells 2 Functions of Skeletal System
More informationMetha Short Hip Stem System
Metha Short Hip Stem System Accuracy That Stands Alone Aesculap Orthopaedics Metha Short Hip Stem System Designed For Anatomic Accuracy The Metha Short Hip Stem is designed for anatomic accuracy to restore
More informationCalcium Phosphate Bone Void Filler TECHNIQUE GUIDE
Calcium Phosphate Bone Void Filler TECHNIQUE GUIDE Features Easily shaped and molded for implantation into defects positioned at difficult angles Hardens in a warm, wet environment, reducing the need to
More informationMicroparticulate Cortical Allograft: An Alternative to Autograft in the Treatment of Osseous Defects
The Open Orthopaedics Journal, 2008, 2, 91-96 91 Open Access Microparticulate Cortical Allograft: An Alternative to Autograft in the Treatment of Osseous Defects H. Thomas Temple * and Theodore I. Malinin
More informationAnkle and subtalar arthrodesis
OSTEOAMP Allogeneic Morphogenetic Proteins Ankle Nonunions OSTEOAMP Case Report ANKLE NONUNIONS Dr. Jason George DeVries Orthopedic & Sports Medicine, Bay Care Clinic, 501 N. 10th Street, Manitowoc, WI
More informationResection of Thumb Metacarpal Ewing Sarcoma and Primary Reconstruction with Non-Vascularized Osteoarticular Metatarsal Autograft
Resection of Thumb Metacarpal Ewing Sarcoma and Primary Reconstruction with Non-Vascularized Osteoarticular Metatarsal Autograft Ariff MS a,b, Faisham WI a, Krishnan J a, Zulmi W a a Orthopaedic Oncology
More informationWrist Joint Reconstruction With a Vascularized Fibula Free Flap Following Giant Cell Tumor Excision in the Distal Radius
Wrist Joint Reconstruction With a Vascularized Fibula Free Flap Following Giant Cell Tumor Excision in the Distal Radius Chester J. Mays, BS, a Kyle Ver Steeg, MD, a Saeed Chowdhry, MD, b David Seligson,
More informationSpine A Preliminary Study of the Efficacy of Beta-Tricalcium Phosphate as a Bone Graft Expander for Instrumented Posterolateral Fusions
Bibliography Spine Epstein, N.E., A Preliminary Study of the Efficacy of Beta-Tricalcium Phosphate as a Bone Graft Expander for Instrumented Posterolateral Fusions. Journal of Spinal Disorders and Techniques,
More informationHistory. 33 y/o F with hx of palpable anterior tibial mass x 2 years, only painful with palpation
History 33 y/o F with hx of palpable anterior tibial mass x 2 years, only painful with palpation Imaging Photo Album Patient also had a smaller lesion 1 cm proximal to this lesion, not seen radiographically.
More informationIsolated Subtalar or Talonavicular Fusion Has Failed. Now What?
Isolated Subtalar or Talonavicular Fusion Has Failed. Now What? Anish R. Kadakia MD Associate Professor Northwestern University: Feinberg School of Medicine Northwestern Memorial Hospital Department of
More informationctive Bone Bonding Bone Regeneration Osteostimulation*
www.bonalive.com ctive Bone Bonding Bone Regeneration Osteostimulation* A revolution in bone grafting Osteoconductive bone graft substitute with osteostimulative* properties *non-osteoinductive Before
More informationAllograft Bone and Super Critical Fluid (SCF) Technology
Allograft Bone and Super Critical Fluid (SCF) Technology Summary: 1. Supercritical Fluids (SCF) have the properties of a gas and a liquid when it is in its supercritical state; 2. SCF treatment provides
More informationPEM GUIDE CHILDHOOD FRACTURES
PEM GUIDE CHILDHOOD FRACTURES INTRODUCTION Skeletal injuries account for 10-15% of all injuries in children; 20% of those are fractures, 3 out of 4 fractures affect the physis or growth plate. Always consider
More informationPhyseal Fractures and Growth Arrest
Physeal Fractures and Growth Arrest Raymond W. Liu, M.D. Victor M. Goldberg Master Clinician-Scientist in Orthopaedics Rainbow Babies and Children s Hospital Case Western Reserve University Outline General
More informationOsseous Tissue and Bone Structure
C h a p t e r 6 Osseous Tissue and Bone Structure PowerPoint Lecture Slides prepared by Jason LaPres Lone Star College - North Harris Copyright 2009 Pearson Education, Inc., publishing as Pearson Benjamin
More informationIncorporation and biodegradation of hydroxyapatite tricalcium phosphate implanted in large metaphyseal defects An animal study
Indian Journal of Experimental Biology Vol. 46, December 008, pp. 836-841 Incorporation and biodegradation of hydroxyapatite tricalcium phosphate implanted in large metaphyseal defects An animal study
More informationSkeletal System worksheet
Skeletal System worksheet Name Section A: Intro to Skeletal System The skeletal system performs vital functions that enable us to move through our daily lives. Support - The skeleton provides support and
More informationInion OTPS TM. The Biodegradable Solution. lnion OTPS TM Plating Systems. Product description
Inion OTPS TM 2 lnion OTPS TM Plating Systems The Biodegradable Solution Bio-advantage with Inion Technology Core Technology Inion s core technology is based on the biological and mechanical principles
More informationSurgery-Ortho. Fractures of the tibia and fibula. Management. Treatment of low energy fractures. Fifth stage. Lec-6 د.
Fifth stage Lec-6 د. مثنى Surgery-Ortho 28/4/2016 Indirect force: (low energy) Fractures of the tibia and fibula Twisting: spiral fractures of both bones Angulatory: oblique fractures with butterfly segment.
More informationBone tumors. RMG: jan
Bone tumors RMG: jan 217. @Kijohs KIZZA JOHN KIJOHS Diseases arising in bone Lipoma Fibrous cortical defects Non-ossifying fibroma Bone island Benign simple cysts Enchondroma Osteochondroma Osteoid osteoma
More informationKnee Revision. Portfolio
Knee Revision Portfolio I use the DePuy Revision Knee System because of its versatility. With this system I can solve nearly any situation I encounter in the OR. Dr. Thomas Fehring, OrthoCarolina Hip and
More informationGIANT CELL TUMOR OF TENDON SHEATH A CYTO HISTO CORRELATION
GIANT CELL TUMOR OF TENDON SHEATH A CYTO HISTO CORRELATION Dr.S.SRIKANTH, Assistant Professor.Dept of Patholgy. Dr.SMITHA VADANA, Resident.Dept of pathology. Dr.R.SUHELA. Resident.Dept Of Pathology. Prathima
More informationTumor Treated by Endoscopy
Original Article Clinics in Orthopedic Surgery 2014;6:72-79 http://dx.doi.org/10.4055/cios.2014.6.1.72 Tumor Treated by Endoscopy Young Choi, MD, Jae Man Kwak, MD, So Hak Chung, MD, Gu Hee Jung, MD, Jae
More informationGiant Cell Tumour of the Distal Radius: Wide Resection and Reconstruction by Non-vascularised Proximal Fibular Autograft
900 Original Article Giant Cell Tumour of the Distal Radius: Wide Resection and Reconstruction by Non-vascularised Proximal Fibular Autograft Ayman Abdelaziz Bassiony, 1 MD Abstract Introduction: Giant
More informationManagement of infected custom mega prosthesis by Ilizarov method
International Journal of Research in Medical Sciences Gudaru K et al. Int J Res Med Sci. 2015 Dec;3(12):3874-3878 www.msjonline.org pissn 2320-6071 eissn 2320-6012 Case Report DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20151459
More informationFluid-fluid levels in bone tumors: A pictorial review
Fluid-fluid levels in bone tumors: A pictorial review Poster No.: C-578 Congress: ECR 2009 Type: Educational Exhibit Topic: Musculoskeletal Authors: L. Figueroa Nasra, C. Martín Hervás, M. Tapia-Viñé,
More informationBEGO BIOMATERIALS When the result counts
BEGO BIOMATERIALS When the result counts Partners in Progress INTRO Challenge what exists get the right answers We practise systematic thinking with a passion and we are never satisfied with the status
More informationTHE NEXT FRONTIER OF BONE REGENERATION. where Technology meets Nature
THE NEXT FRONTIER OF BONE REGENERATION where Technology meets Nature SmartBone is a new hybrid bioactive bone substitute specifically developed for bone regeneration in reconstructive surgery. SmartBone
More informationCASE REPORT. Bone transport utilizing the PRECICE Intramedullary Nail for an infected nonunion in the distal femur
PRODUCTS CASE REPORT Bone transport utilizing the PRECICE Intramedullary Nail for an infected nonunion in the distal femur Robert D. Fitch, M.D. Duke University Health System 1 1 CONDITION Infected nonunion
More informationMethods Used for Reconstruction in Aggressive Bone Tumours: An Early Experience
ORIGINAL ARTICLE Methods Used for Reconstruction in Aggressive Bone Tumours: An Early Experience K L Pan, FRCS*, S STing, FRCS**, A W K Mohamad, MS (Orth)*, W GLee, FRCS**, C C Wong, FRCS**, A H Rasit,
More informationBIOACTIVE SYNTHETIC GRAFT
B U I L D S T R O N G B O N E F A S T Putty Particulate Morsels A BIOACTIVE SYNTHETIC BONE FOR FASTER HEALING NovaBone is a 100% bioactive synthetic material composed from elements that occur naturally
More informationTypical skeletal location and differential diagnosis of bone tumors.
Typical skeletal location and differential diagnosis of bone tumors. Poster No.: C-2418 Congress: ECR 2015 Type: Educational Exhibit Authors: M. Barros, L. A. Ferreira, Y. Costa, P. J. V. Coelho, F. Caseiro
More informationCERAMENT BONE VOID FILLER
CERAMENT BONE VOID FILLER Rapid and complete bone remodeling TM CERAMENT BONE VOID FILLER CERAMENT is an injectable, moldable, drillable and radiopaque bone substitute which provides rapid and complete
More informationThe Skeletal System. Chapter 7a. Skeletal System Introduction Functions of the skeleton Framework of bones The skeleton through life
The Skeletal System Skeletal System Introduction Functions of the skeleton Framework of bones The skeleton through life Chapter 7a Support Protection Movement Storage areas Minerals Lipids Hemopoiesis
More informationChondroblastoma associated with aneurysmal cyst of the navicular bone: a case report
Fang and Chen World Journal of Surgical Oncology 2013, 11:50 WORLD JOURNAL OF SURGICAL ONCOLOGY CASE REPORT Open Access Chondroblastoma associated with aneurysmal cyst of the navicular bone: a case report
More informationTHE NEXT FRONTIER OF BONE REGENERATION. where Technology meets Nature
THE NEXT FRONTIER OF BONE REGENERATION where Technology meets Nature SmartBone is a new hybrid bioactive bone substitute specifically developed for bone regeneration in reconstructive surgery. SmartBone
More informationSoft-tissue Recurrence of Giant Cell tumor of Bone Associated with Pulmonary Metastases.
Soft-tissue Recurrence of Giant Cell tumor of Bone Associated with Pulmonary Metastases. M. M. Abdel- Motaal 1, A. S. Othman 1, M. K. C. Katchy 2, A. K. Jassar 3 1 Al-Razi Orthopaedic Hospital, Kuwait,
More informationTalos -C (HA) and the PEEK-OPTIMA HA Enhanced Technology
v Talos -C (HA) and the HA Enhanced Technology The innovative Talos -C (HA) IBF Implant made with polymer is fully integrated with the well known material Hydroxyapatite (HA). The Talos -C (HA) IBF Implant
More informationPost-traumatic osteonecrosis of distal tibia
Injury Extra (2007) 38, 262 266 www.elsevier.com/locate/inext CASE REPORT Post-traumatic osteonecrosis of distal tibia D. Chakravarty a, *, A. Khanna a,1, A. Kumar b,2 a Department of Orthopaedics, Peterborough
More informationchronos Inject. Synthetic Bone Substitute Injectable, Osteoconductive, Resorbable.
chronos Inject. Synthetic Bone Substitute Injectable, Osteoconductive, Resorbable. Technique Guide The answer to bone voids Table of contents Introduction 2 Case Study 3 Indications and Contraindications
More information